Multidrug resistance is one of the major obstacles in the treatment of cancers. This
undesirable feature increases the mortality rate of cancers, including breast cancer. Circular …

CircRNAs are associated with adriamycin (ADM) resistance in triple‑negative breast cancer
(TNBC), but the mechanism is unknown. Reverse transcription‑quantitative PCR was …

Aim: We aimed to identify circular RNAs (circRNAs) associated with breast cancer
chemoresistance. Materials & methods: CircRNA microarray expression profiles were …

Background Circular RNAs (circRNAs) have been reported to be involved in regulating the
development of breast cancer. Paclitaxel (PTX) can be used for the chemotherapy of breast …

Background Chemotherapeutic resistance is the main cause of clinical treatment failure and
poor prognosis in triple-negative breast cancer (TNBC). There is no research on …

Breast cancer (BC) is the most common heterogeneous disease in women and one of the
leading causes of cancer-related death. Surgery, chemotherapy, radiotherapy, hormone …

Circular RNAs (circRNAs) are reported to be related to cancer chemoresistance. However,
the role of circ_0085495 in adriamycin (ADM) and its action mechanism has not been …

Among cancers, breast cancer has the highest incidence rate among women and poses a
tremendous threat to women's health. Messenger RNA (mRNA), microRNA (miRNA) and …

Background Drug-resistance is a major obstacle to the treatment of breast cancer. Circular
RNA (circRNA) circ-MMP11 has been reported to be promoting the progression of breast …

To investigate the relationship between non-coding RNAs [especially circular RNAs
(circRNAs)] and docetaxel resistance in breast cancer, and to find potential predictive …